---
title: "Esco Technologies schedules fiscal Q3 earnings release, conference call"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293517020.md"
description: "Esco Technologies will release its fiscal Q3 2026 earnings results on August 6, 2026, after market close. A conference call with management will follow at 4:00 p.m. Central time, accessible via webcast through the Investor Center or registration link."
datetime: "2026-07-22T20:24:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293517020.md)
  - [en](https://longbridge.com/en/news/293517020.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293517020.md)
generator: "portal-rs"
---

# Esco Technologies schedules fiscal Q3 earnings release, conference call

-   ESCO Technologies will release fiscal Q3 2026 results on Aug. 6, 2026, following the market close. \* Management will host a conference call on Aug. 6 at 4:00 p.m. Central; webcast via Investor Center (here) or registration link (here). Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Esco Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607221615PRIMZONEFULLFEED9766351) on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ESE.US](https://longbridge.com/en/quote/ESE.US.md)

## Related News & Research

- [NGEx Minerals to host investor day webcast](https://longbridge.com/en/news/298297598.md)
- [NervGen to host inaugural R&D Day webcast on NVG-291 program](https://longbridge.com/en/news/298449939.md)
- [BIC to webcast strategic plan update for 2030 targets](https://longbridge.com/en/news/298225164.md)
- [Arverne Group updates financial calendar with upcoming interim results release and investor webcast](https://longbridge.com/en/news/298346254.md)
- [Pyxis Oncology to webcast updated Phase 1 MICVO monotherapy data in recurrent/metastatic head and neck cancer](https://longbridge.com/en/news/298359153.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**